- ISIN
- US44934S2068
- CUSIP
- 44934S206
- Sector
- Healthcare
- Industry
- Health Information Services
- IPO Date
- Dec 3, 1986
Highlights
- Total Revenue (TTM)
- $19.53M
- Gross Profit (TTM)
- $16.77M
- EBITDA (TTM)
- -$4.84M
- Year Range
- $3.58 - $4.00
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ICAD Performance Chart
Loading charts...
Returns By Period
iCAD, Inc.
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 0.13%
- 1M
- 5.25%
- YTD
- 11.16%
- 6M
- 11.43%
- 1Y
- 28.20%
- 3Y*
- 21.12%
- 5Y*
- 12.66%
- 10Y*
- 13.75%
ICAD Monthly Returns History
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 74.86% | -24.69% | -14.52% | 66.02% | 12.28% | -0.78% | 1.57% | 111.48% | |||||
| 2024 | -23.73% | 32.59% | -10.06% | -11.18% | 1.40% | -10.34% | 1.54% | 21.97% | -2.80% | 18.85% | -6.99% | 5.78% | 3.39% |
| 2023 | 25.14% | 15.72% | -53.21% | 16.94% | -11.03% | 26.36% | 69.94% | -17.69% | -7.46% | -36.49% | 20.15% | 9.94% | -3.28% |
| 2022 | -22.36% | -13.60% | -7.66% | -19.28% | 6.11% | 4.71% | -6.75% | -19.30% | -30.23% | -9.05% | -5.76% | 1.67% | -74.58% |
| 2021 | 15.08% | 21.72% | 14.76% | -14.99% | -8.81% | 5.23% | -15.31% | -17.74% | -10.86% | -1.86% | -30.14% | -2.31% | -45.45% |
Benchmark Metrics
iCAD, Inc. has an annualized alpha of 34.66%, beta of 0.68, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since March 18, 1992.
- This stock participated in 159.57% of S&P 500 Index downside but only 91.60% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.68 may look defensive, but with R2 of 0.02 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 34.66%
- Beta
- 0.68
- R²
- 0.02
- Upside Capture
- 91.60%
- Downside Capture
- 159.57%
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for iCAD, Inc. (ICAD) and compare them to S&P 500 Index.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the iCAD, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the iCAD, Inc. was 98.74%, occurring on May 16, 2023. The portfolio has not yet recovered.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2023 bear market2023 | -98.74%May 2023 | 30y 5mo | — | 33y 6moDec 1992 - now |
1992 bear market1992 | -35.87%Aug 1992 | 3mo 7d | 2mo 10d | 5mo 17dMay 1992 - Nov 1992 |
1992 bear market1992 | -26.00%Apr 1992 | 1mo 3d | 28d | 2mo 1dMar 1992 - May 1992 |
1992 pullback1992 | -5.35%Nov 1992 | 1d | 2d | 3dNov 1992 - Nov 1992 |
1992 pullback1992 | -4.62%Nov 1992 | 1d | 2d | 3dNov 1992 - Nov 1992 |
Drawdown Indicators
| ICAD | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -56.78% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -9.10% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | — | 0.00% | — |
Average DrawdownAverage peak-to-trough decline | — | -10.72% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 1.97% | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of iCAD, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how iCAD, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ICAD
Add iCAD, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ICAD